Charlene Thomas

ORCID: 0000-0002-7685-0090
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Prostate Cancer Treatment and Research
  • Radiopharmaceutical Chemistry and Applications
  • BRCA gene mutations in cancer
  • Medical Imaging Techniques and Applications
  • Alzheimer's disease research and treatments
  • Genetic Associations and Epidemiology
  • Cancer Immunotherapy and Biomarkers
  • COVID-19 and healthcare impacts
  • Ovarian cancer diagnosis and treatment
  • Genomics and Rare Diseases
  • Cancer Genomics and Diagnostics
  • Bladder and Urothelial Cancer Treatments
  • Pregnancy and preeclampsia studies
  • Bioinformatics and Genomic Networks
  • Epigenetics and DNA Methylation
  • Mass Spectrometry Techniques and Applications
  • Genetic factors in colorectal cancer
  • Urinary and Genital Oncology Studies
  • Adrenal Hormones and Disorders
  • Prenatal Screening and Diagnostics
  • Assisted Reproductive Technology and Twin Pregnancy
  • COVID-19 Impact on Reproduction
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Diversity and Career in Medicine
  • Congenital Diaphragmatic Hernia Studies

Weill Cornell Medicine
2017-2025

Cornell University
2017-2025

University Hospital Llandough
2024

Presbyterian Hospital
2020-2024

New York Hospital Queens
2021-2024

NewYork–Presbyterian Hospital
2020-2024

Molecular Biology Consortium
2023

Cardiff University
2009-2022

Creative Commons
2021

Institute of Population and Public Health
2021

10.1038/ng.440 article EN Nature Genetics 2009-09-06
Valentina Escott‐Price Céline Bellenguez Li‐San Wang Seung‐Hoan Choi Denise Harold and 95 more Lesley Jones Peter Holmans Amy Gerrish Alexey Vedernikov Alexander Richards Anita L. DeStefano Jean‐Charles Lambert Carla A. Ibrahim‐Verbaas Adam C. Naj Rebecca Sims Gyungah Jun Joshua C. Bis Gary W. Beecham Benjamin Grenier‐Boley Giancarlo Russo Tricia A. Thornton‐Wells Nicola Denning Albert V. Smith Vincent Chouraki Charlene Thomas M. Arfan Ikram Diana Zélénika Badri N. Vardarajan Yoichiro Kamatani Chiao‐Feng Lin Helena Schmidt Brian W. Kunkle Melanie Dunstan Maria Vronskaya Andrew D. Johnson Agustı́n Ruiz Marie‐Thérèse Bihoreau Christiane Reitz Florence Pasquier Paul Hollingworth Olivier Hanon Annette L. Fitzpatrick Joseph D. Buxbaum Dominique Campion Paul K. Crane Clinton T. Baldwin Tim Becker Vilmundur Guðnason Carlos Cruchaga David Craig Najaf Amin Claudine Berr Lorna M. Lopez Philip L. De Jager Vincent Deramecourt Janet Johnston Denis A. Evans Simon Lovestone Luc Letenneur Isabel Hernández David C. Rubinsztein Gudny Eiriksdottir Kristel Sleegers Alison Goate Nathalie Fiévet Matthew J. Huentelman Michael Gill Kristelle Brown M. Ilyas Kamboh Lina Keller Pascale Barberger‐Gateau Bernadette McGuinness Eric B. Larson Amanda Myers Carole Dufouil Stephen Todd David Wallon Seth Love Ekaterina Rogaeva John Gallacher Peter St George‐Hyslop Jordi Clarimón Alberto Lleó Antony Bayer Debby W. Tsuang Lei Yu Magda Tsolaki Paola Bossù Gianfranco Spalletta Petroula Proitsi John Collinge Sandro Sorbi Florentino Sánchez-García Nick C. Fox John Hardy María Cándida Déniz Naranjo Paolo Bosco Robert Clarke Carol Brayne Daniela Galimberti

Background Alzheimer's disease is a common debilitating dementia with known heritability, for which 20 late onset susceptibility loci have been identified, but more remain to be discovered. This study sought identify new genes, using an alternative gene-wide analytical approach tests patterns of association within in the powerful genome-wide dataset International Genomics Project Consortium, comprising over 7 m genotypes from 25,580 cases and 48,466 controls. Principal Findings In addition...

10.1371/journal.pone.0094661 article EN cc-by PLoS ONE 2014-06-12
Lesley Jones Jean‐Charles Lambert Weixin Wang Seung‐Hoan Choi Denise Harold and 95 more Alexey Vedernikov Valentina Escott‐Price Timothy Stone Alexander Richards Céline Bellenguez Carla A. Ibrahim‐Verbaas Adam C. Naj Rebecca Sims Amy Gerrish Gyungah Jun Anita L. DeStefano Joshua C. Bis Gary W. Beecham Benjamin Grenier‐Boley Giancarlo Russo Tricia A. Thornton‐Wells Nicola Jones Albert V. Smith Vincent Chouraki Charlene Thomas M. Arfan Ikram Diana Zélénika Badri N. Vardarajan Yoichiro Kamatani Chiao‐Feng Lin Helena Schmidt Brian W. Kunkle Melanie Dunstan Agustı́n Ruiz Marie‐Thérèse Bihoreau Christiane Reitz Florence Pasquier Paul Hollingworth Olivier Hanon Annette L. Fitzpatrick Joseph D. Buxbaum Dominique Campion Paul K. Crane Tim Becker Vilmundur Guðnason Carlos Cruchaga David W. Craig Najaf Amin Claudine Berr Oscar L. López Philip L. De Jager Vincent Deramecourt Janet Johnston Denis A. Evans Simon Lovestone Luc Letteneur Johanes Kornhuber Lluís Tárraga David C. Rubinsztein Gudny Eiriksdottir Kristel Sleegers Alison Goate Nathalie Fiévet Matthew J. Huentelman Michael Gill Valur Emilsson Kristelle Brown M. Ilyas Kamboh Lina Keller Pascale Barberger‐Gateau Bernadette McGuinness Eric B. Larson Amanda Myers Carole Dufouil Stephen Todd David Wallon Seth Love Patrick G. Kehoe Ekaterina Rogaeva John Gallacher Peter St George‐Hyslop Jordi Clarimón Alberti Lleὀ Antony Bayer Debby W. Tsuang Lei Yu Magda Tsolaki Paola Bossù Gianfranco Spalletta Petroula Proitsi John Collinge Sandro Sorbi Florentino Sánchez-García Nick C. Fox John Hardy María Cándida Déniz Naranjo Cristina Razquín Paola Bosco Robert Clarke Carol Brayne

Abstract Background Late‐onset Alzheimer's disease (AD) is heritable with 20 genes showing genome‐wide association in the International Genomics of Project (IGAP). To identify biology underlying disease, we extended these genetic data a pathway analysis. Methods The ALIGATOR and GSEA algorithms were used IGAP to associated functional pathways correlated gene expression networks human brain. Results identified an excess curated biological enrichment association. Enriched areas included immune...

10.1016/j.jalz.2014.05.1757 article EN Alzheimer s & Dementia 2014-12-19

Importance A nonadjuvanted bivalent respiratory syncytial virus (RSV) prefusion F (RSVpreF [Pfizer]) protein subunit vaccine was newly approved and recommended for pregnant individuals at 32 0/7 to 36 6/7 weeks’ gestation during the 2023 2024 RSV season; however, clinical data are lacking. Objective To evaluate association between prenatal vaccination status perinatal outcomes among patients who delivered season. Design, Setting, Participants This retrospective observational cohort study...

10.1001/jamanetworkopen.2024.19268 article EN cc-by-nc-nd JAMA Network Open 2024-07-08

BackgroundThe coronavirus disease 2019 pandemic has resulted in unprecedented challenges for the oncology community. For people living with cancer, treatments are interrupted, surgeries cancelled, and regular evaluations rescheduled. People cancer their physicians must balance plausible fears of treatment consequences delaying care.ObjectiveWe aim to evaluate experience women ovarian during pandemic.Study DesignWomen a current or previous diagnosis completed an online survey focusing on...

10.1016/j.ajog.2020.06.049 article EN other-oa American Journal of Obstetrics and Gynecology 2020-06-26

PURPOSE Novel therapies are needed to extend survival in metastatic castration-resistant prostate cancer (mCRPC). Prostate-specific membrane antigen (PSMA), a cell surface overexpressed PC, provides validated target. This dose-escalation study investigated the safety, efficacy, maximum tolerated dose (MTD), and recommended phase II (RP2D) for 225 Ac-J591, anti-PSMA monoclonal antibody J591 radiolabeled with alpha emitter actinium-225. METHODS Following investigational new drug-enabling...

10.1200/jco.23.00573 article EN Journal of Clinical Oncology 2023-11-03

Rare mutations in AβPP, PSEN1, and PSEN2 cause uncommon early onset forms of Alzheimer's disease (AD), common variants MAPT are associated with risk other neurodegenerative disorders. We sought to establish whether genetic variation these genes confer the form AD which occurs later life (>65 years). therefore tested single-nucleotide polymorphisms at loci for association late-onset (LOAD) a large case-control sample consisting 3,940 cases 13,373 controls. Single-marker analysis did not...

10.3233/jad-2011-110824 article EN other-oa Journal of Alzheimer s Disease 2012-01-25

The extent to which severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection at different points in the pregnancy timeline may affect maternal and fetal outcomes remains unknown. We sought characterize impact of SARS-CoV-2 proximate remote from delivery on placental pathology. performed a secondary analysis pathology prospective cohort universally tested positive women >20 weeks gestation 1 institution. Subjects were categorized as having or nonacute based <14 ≥14 days...

10.1097/pas.0000000000001772 article EN The American Journal of Surgical Pathology 2021-07-26

BACKGROUND New York City (NYC) emerged as an epicenter of the COVID‐19 pandemic, and marginalized populations were affected at disproportionate rates. The authors sought to determine impact on cancer treatment, anxiety, financial distress among low‐income patients with gynecologic during peak NYC pandemic. METHODS Medicaid‐insured women who receiving oncology care 2 affiliated centers contacted by telephone interviews between March 15 April 15, 2020. Demographics clinical characteristics...

10.1002/cncr.33537 article EN Cancer 2021-04-26

Prostate-specific membrane antigen (PSMA) imaging has been suggested as highly sensitive modality for detection of metastases in patients with biochemically recurrent or advanced prostate cancer (PCa). PSMA expression is associated grade and stage a relationship androgen receptor signaling. The aim this study was to evaluate the prognostic utility radiographic men metastatic castration-resistant (mCRPC).Patients mCRPC available baseline were studied. Images by planar/single-photon emission...

10.3389/fonc.2021.630589 article EN cc-by Frontiers in Oncology 2021-02-18

Background: The COVID-19 pandemic has resulted in unprecedented challenges for people living with cancer, impacting not only physical health but psychological well-being. response affects the individual as well community and can persist long after outbreak. We aim to assess coping strategies employed by women ovarian cancer during pandemic.Methods: Women a current or prior diagnosis of completed an online survey which included query about pandemic. was distributed from March 30th through...

10.1016/j.ygyno.2020.11.017 article EN other-oa Gynecologic Oncology 2020-11-20

Currently available SARS-CoV-2 therapeutics are targeted toward moderately to severely ill patients and require intravenous infusions, with limited options for exposed or infected no mild symptoms. Although vaccines have demonstrated protective efficacy, vaccine hesitancy logistical distribution challenges will delay their ability end the pandemic. Hence, there is a need rapidly translatable, easy-to-administer-therapeutics that can prevent disease progression, when administered in early...

10.1016/j.isci.2021.103412 article EN cc-by-nc-nd iScience 2021-11-10

ObjectivesApproximately 1% of individuals have a hereditary cancer predisposition syndrome, however, the majority are not aware. Collecting family history (CFH) can triage patients to receive genetic testing. To rigorously assess different methods CFH collection, we compared web-based tool (WBT) usual care (clinician collects CFH) in randomized controlled trial.MethodsNew gynecologic oncology (seen 9/2019–9/2021) were one three arms 2:2:1 allocation ratio: 1) clinician 2) WBT completed at...

10.1016/j.ygyno.2023.04.001 article EN cc-by-nc-nd Gynecologic Oncology 2023-04-14

172 Background: Up to 1/3 of pts develop biochemical relapse following primary therapy. Many are not cured with salvage local therapy, likely because undetectable distant disease. PSMA is expressed on most PC and can be targeted by radiolabeled J591. 177 Lu a predominantly β-emitting radionuclide also has γ emission which allows imaging. 111 In emitter, some auger for Hormonal therapy effective may increase expression radiosensitivity. this DOD-funded study initiated in the pre-PSMA PET AR...

10.1200/jco.2025.43.5_suppl.172 article EN Journal of Clinical Oncology 2025-02-10
Coming Soon ...